Newborn treated with continuous renal replacement therapy for citrulinemia-type 1

Introduction: Hyperammonemia occurs as a result of the inability to convert ammonia, a metabolic toxin, into urea due to a block in the urea cycle, and there resulting neurotoxicity is responsible for the pathogenesis. Case Presentation: Our patient was 7 days old when followed up in an external...

Full description

Bibliographic Details
Main Authors: Tosun Demet, Akcay Nihal, Menentoğlu Emin Mehmet, Şevketoğlu Esra, Salihoğlu Ozgul
Format: Article
Language:English
Published: Association of medical doctors Sanamed Novi Pazar 2022-12-01
Series:Sanamed
Subjects:
Online Access:https://www.sanamed.rs/OJS/index.php/Sanamed/article/view/558/309
_version_ 1797281084135702528
author Tosun Demet
Akcay Nihal
Menentoğlu Emin Mehmet
Şevketoğlu Esra
Salihoğlu Ozgul
author_facet Tosun Demet
Akcay Nihal
Menentoğlu Emin Mehmet
Şevketoğlu Esra
Salihoğlu Ozgul
author_sort Tosun Demet
collection DOAJ
description Introduction: Hyperammonemia occurs as a result of the inability to convert ammonia, a metabolic toxin, into urea due to a block in the urea cycle, and there resulting neurotoxicity is responsible for the pathogenesis. Case Presentation: Our patient was 7 days old when followed up in an external center for 3 days with a preliminary diagnosis of neonatal sepsis. Lethargy, vomiting, tachypnea, and convulsions, which are frequently seen in the first neonatal forms of urea cycle disorders, were also present in our patient. He was referred to us as a result of high ammonia levels when he was examined in terms of congenital metabolic diseases. He was intubated due to the rapid development of respiratory failure. When he was admitted to our intensive care unit with hyperammonemia, light reflex could not be obtained, and widespread cutis marmaratus was developed. Continuous renal replacement therapy was started in our patient and administered intermittently for 120 hours. The glucose infusion rate was followed by high fluid. When it orally tolerated, it is supported with sodium benzoate and sodium stearyl fumarate to reduce ammonia. Nutrition was limited to protein with Basic P. Conclusion: After staying in the intensive care unit for 30 days, our patient was discharged with the recommendation of outpatient follow-up by the pediatric metabolism physician. When our patient came for his check up after two months,there was no nystagmus and no seizures.
first_indexed 2024-03-07T16:51:25Z
format Article
id doaj.art-c4e43d63f0d04304a7ce41ed84e694a5
institution Directory Open Access Journal
issn 1452-662X
2217-8171
language English
last_indexed 2024-03-07T16:51:25Z
publishDate 2022-12-01
publisher Association of medical doctors Sanamed Novi Pazar
record_format Article
series Sanamed
spelling doaj.art-c4e43d63f0d04304a7ce41ed84e694a52024-03-03T05:23:08ZengAssociation of medical doctors Sanamed Novi PazarSanamed1452-662X2217-81712022-12-0117317517810.5937/sanamed0-40473Newborn treated with continuous renal replacement therapy for citrulinemia-type 1Tosun Demet0Akcay Nihal1Menentoğlu Emin Mehmet2Şevketoğlu Esra3Salihoğlu Ozgul4Department of Pediatric Intensive Care Unit, Bakırköy Dr. Sadi Konuk Research and Training Hospital, University of Health Sciences, Istanbul, TurkeyDepartment of Pediatric Intensive Care Unit, Bakırköy Dr. Sadi Konuk Research and Training Hospital, University of Health Sciences, Istanbul, TurkeyDepartment of Pediatric Intensive Care Unit, Bakırköy Dr. Sadi Konuk Research and Training Hospital, University of Health Sciences, Istanbul, TurkeyDepartment of Pediatric Intensive Care Unit, Bakırköy Dr. Sadi Konuk Research and Training Hospital, University of Health Sciences, Istanbul, TurkeyNewborn Intensive Care Unit, Bakırköy Dr. Sadi Konuk Research and Training Hospital, University of Health Sciences, Istanbul, TurkeyIntroduction: Hyperammonemia occurs as a result of the inability to convert ammonia, a metabolic toxin, into urea due to a block in the urea cycle, and there resulting neurotoxicity is responsible for the pathogenesis. Case Presentation: Our patient was 7 days old when followed up in an external center for 3 days with a preliminary diagnosis of neonatal sepsis. Lethargy, vomiting, tachypnea, and convulsions, which are frequently seen in the first neonatal forms of urea cycle disorders, were also present in our patient. He was referred to us as a result of high ammonia levels when he was examined in terms of congenital metabolic diseases. He was intubated due to the rapid development of respiratory failure. When he was admitted to our intensive care unit with hyperammonemia, light reflex could not be obtained, and widespread cutis marmaratus was developed. Continuous renal replacement therapy was started in our patient and administered intermittently for 120 hours. The glucose infusion rate was followed by high fluid. When it orally tolerated, it is supported with sodium benzoate and sodium stearyl fumarate to reduce ammonia. Nutrition was limited to protein with Basic P. Conclusion: After staying in the intensive care unit for 30 days, our patient was discharged with the recommendation of outpatient follow-up by the pediatric metabolism physician. When our patient came for his check up after two months,there was no nystagmus and no seizures.https://www.sanamed.rs/OJS/index.php/Sanamed/article/view/558/309hyperammonemianewbornsepsis
spellingShingle Tosun Demet
Akcay Nihal
Menentoğlu Emin Mehmet
Şevketoğlu Esra
Salihoğlu Ozgul
Newborn treated with continuous renal replacement therapy for citrulinemia-type 1
Sanamed
hyperammonemia
newborn
sepsis
title Newborn treated with continuous renal replacement therapy for citrulinemia-type 1
title_full Newborn treated with continuous renal replacement therapy for citrulinemia-type 1
title_fullStr Newborn treated with continuous renal replacement therapy for citrulinemia-type 1
title_full_unstemmed Newborn treated with continuous renal replacement therapy for citrulinemia-type 1
title_short Newborn treated with continuous renal replacement therapy for citrulinemia-type 1
title_sort newborn treated with continuous renal replacement therapy for citrulinemia type 1
topic hyperammonemia
newborn
sepsis
url https://www.sanamed.rs/OJS/index.php/Sanamed/article/view/558/309
work_keys_str_mv AT tosundemet newborntreatedwithcontinuousrenalreplacementtherapyforcitrulinemiatype1
AT akcaynihal newborntreatedwithcontinuousrenalreplacementtherapyforcitrulinemiatype1
AT menentoglueminmehmet newborntreatedwithcontinuousrenalreplacementtherapyforcitrulinemiatype1
AT sevketogluesra newborntreatedwithcontinuousrenalreplacementtherapyforcitrulinemiatype1
AT salihogluozgul newborntreatedwithcontinuousrenalreplacementtherapyforcitrulinemiatype1